ANTINEOPLASTIC COMBINATIONS WITH MTOR INHIBITOR, HERCEPTIN, AND/OR HKI-272

• 收藏
• 分享

专利权人:

发明人:

申请号：

HK13112663.6

公开号：

HK1185263A

申请日:

2013.11.12

申请国别(地区):

HK

年份:

2014

代理人:

摘要：

A combination of temsirolimus and herceptin in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of herceptin and HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing herceptin, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/